Results 231 to 240 of about 30,070 (260)
Some of the next articles are maybe not open access.
2021
In the 2017 WHO classification, chronic myeloid neoplasms include myeloproliferative neoplasms (MPNs), myelodysplastic/myeloproliferative neoplasms (MDS/MPNs), myelodysplastic syndrome (MDS), mastocytosis and myeloid/lymphoid neoplasms with eosinophilia with rearrangements in FGFR1, PDGFRA, PDGFRB, or PCM1-JAK2 fusions.
Julie Li, Gang Zheng
openaire +1 more source
In the 2017 WHO classification, chronic myeloid neoplasms include myeloproliferative neoplasms (MPNs), myelodysplastic/myeloproliferative neoplasms (MDS/MPNs), myelodysplastic syndrome (MDS), mastocytosis and myeloid/lymphoid neoplasms with eosinophilia with rearrangements in FGFR1, PDGFRA, PDGFRB, or PCM1-JAK2 fusions.
Julie Li, Gang Zheng
openaire +1 more source
Cytogenetics of Myeloproliferative Neoplasms
2011The introduction of JAK2 mutation testing has changed dramatically the diagnostic algorithms for myeloproliferative neoplasms (MPNs) but there is still a place for conventional cytogenetic analysis in the initial work-up of MPN cases, particularly as this group of myeloid disorders has been expanded to include chronic eosinophilic leukaemia and myeloid
openaire +2 more sources
Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms
2011Myeloproliferative syndromes (MPS) are characterized by clonal proliferation patterns of hematological precursor cells with a tendency to develop acute leukemia. Cytopenias typically seen in myelodysplastic syndrome (MDS) are uncommon, as are dysplastic morphological features.
openaire +1 more source
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology
Hematology/Oncology Clinics of North America, 2021Daniel Royston +2 more
exaly
Myeloproliferative neoplasms – a global view
British Journal of Haematology, 2022Ayalew Tefferi +6 more
openaire +3 more sources